GlassScriptPhysician profile
Boris Mraovic
NPI 1184640484
$16,711.53
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $91.61 · 2021: $496 · 2022: $164 · 2023: $822 · 2024: $2,491 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,059 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Travel and Lodging: $2,443 · Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,059.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Travel and Lodging | $2,443.25 |
| Food and Beverage | $1,616.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $14,021.78 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $505.37 | 2021-2025 | Caldolor |
| Acacia Pharma INC | $394.91 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $389.51 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $288.39 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $171.87 | 2022-2024 | Exparel |
| Fisher & Paykel Healthcare INC | $148.90 | 2024 | Fisher & Paykel Healthcare |
| Baudax Bio INC. | $121.67 | 2021-2022 | |
| Haemonetics Corporation | $115.00 | 2023 | Teg6s Hemostasis System |
| Cas Medical Systems INC. | $111.56 | 2019 | |
| Heron Therapeutics, INC. | $110.17 | 2023 | Aponvie |
| Avanos Medical | $109.78 | 2019 | |
| Edwards Lifesciences Corporation | $93.07 | 2020-2021 | |
| Stryker Corporation | $74.56 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.18 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $23.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Mraovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.